Outpatient management for PE

In this large multi-center trial of patients with acute symptomatic PE (PE severity index class I or II), they were randomized to in or outpatient treatment with LMWH. There were no significant differences between the groups in 90 day recurrent VTE, death, or major bleeding. LOS was 0.5 days vs 3.9 days. Outpatient therapy is feasible, safe, and lower cost in low risk patients with PE (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment